Andrea Karnitschky

Andrea Karnitschky is a declared insider of Newbury Pharmaceuticals AB, with filings sourced from Finansinspektionen. Over a trading history stretching from 26 August 2022 to 17 January 2023, the count stands at 4 filings.

Every open-market trade on record is a purchase: 3 purchases worth €13k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant. Since January 2023: 1 purchase and no sales on the market.

In size, the median ticket on the buying side is €3,900. Clusters matter here: 2 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 3 purchases with a full 90-day history, the hit rate stands at 67% and the median 90-day move at +66.6%. Past outcomes like these are no guarantee of what comes next.

The newest entry dates from 18 January 2023: an open-market purchase of €5,400, in Newbury Pharmaceuticals AB. Filings reach the Finansinspektionen feed a median of 1 day after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.